Sélectionner une page

7th International Conference for Cancer Immunotherapy & Immunomonitoring (CITIM)

SB-PEPTIDE is pleased to exhibit during the 7th CITIM Internation Conference which will be held in Vilnius, Lithuania, from April 24th to 27th, 2023.

SB-PEPTIDE 7th International Conference for Cancer Immunotherapy & Immunomonitoring participation banner

Meet our delegate on-site !

Custom peptide & express services

Simple to complex peptides, 10 days express service ...

Marine Hoscar

Marine Hoscar

Business Developer & Sales Representative, Spain

After an internship in England, a year in Germany, and my final year of study in Czech Republic, I decided to learn Spanish and broaden my professional skills in Spain. Recently graduated in chemical engineering with a specialization in biochemistry, I decided to temporarily leave the laboratory to learn more about business development. I am pleased to become the main point of contact for all kinds of peptide requests and I hope to meet various scientific experts during this international conference !

Feel free to contact me on LinkedIn Marineor at mh@sb-peptide.com for more information.

About 7th International Conference for Cancer Immunotherapy & Immunomonitoring (CITIM)

This year’s CITIM International Conference will bring the best world clinicians and scientists to Eastern Europe to participate in plenary sessions, symposia and educational workshops designed to maintain, improve and further develop the investigation and practice of malignant diseases. The target audience includes biomedical scientists, medical students, immunologists, medical oncologists, surgical oncologists, hematologists, pathologists, specialty and primary care physicians, and allied health professionals.

Lecturers are invited from the USA, Israel, Germany, France, Italy, Spain, Poland, Netherlands, Denmark, Czech Republic, Australia, UK, Canada and other countries. A special attention will be given to novel therapeutic modalities, tumor immunology and immunotherapy, stem cells, cancer biomarkers, the tumor immunoenvironment and immunomonitoring of the immune status of cancer patients.

Visit the 7th CITIM International Conference website !